GE Healthcare CEO touts radiopharmaceuticals after 3Q earnings beat

GE Healthcare CEO Peter Arduini said radiopharmaceuticals are a fast-growing field advancing cancer treatment, cardiology imaging and neurology, including Alzheimer's-related approaches. Because the products have short half-lives, control of manufacturing and the supply chain is especially important.

• Radiopharmaceuticals are growing in oncology, cardiac imaging and neurology
• Short half-lives make manufacturing and supply chain control critical
• The company reported third-quarter results that beat estimates